Artificial opening status

Z21_ARTIF_OPENI_STATUS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Z93 Cause of death: ICD-10 — Z93 2 out of 7 registries used, show all original rules.	1943
4. Check minimum number of events None	1943
5. Include endpoints None	1943
6. Filter based on genotype QC (FinnGen only)	1943

Control definitions (FinnGen only)

Control exclude: Z21_PERSONS_W_POTEN_HEALTH_HAZARDS_RELATED_FAMILY_PERSONAL_HISTORY_CERTA_CONDI_INFLUENCI_HEALTH_STATUS

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Z[8-9]

NAME	Z21_ARTIF_OPENI_STATUS
CONTROL_EXCLUDE	Z21_PERSONS_W_POTEN_HEALTH_HAZARDS_RELATED_FAMILY_PERSONAL_HISTORY_CERTA_CONDI_INFLUENCI_HEALTH_STATUS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z93
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z93
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Artificial opening status based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1943	897	1046
Unadjusted period prevalence (%)	0.39	0.31	0.46
Median age at first event (years)	66.77	64.73	68.52

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1725: Matched controls
17251

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JFF23

NOMESCO Finland

Transversostomy

142.1

323.0

420

Z93.2

ICD-10 Finland

Ileostomy status

+∞

323.0

434

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

117.9

323.0

356

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

18.1

323.0

759

717

Z93.3

ICD-10 Finland

Colostomy status

16384.0

323.0

973

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

19.1

323.0

686

575

WX302

NOMESCO Finland

Thoracal epidural anesthesy

32.7

323.0

737

384

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

50.2

323.0

650

205

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

46.9

323.0

543

167

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

42.5

323.0

460

146

WX408

NOMESCO Finland

General anesthesy, balanced

7.5

315.6

1042

2907

B01AB05

ATC

enoxaparin; parenteral

6.6

281.5

1045

3248

JN4BD

NOMESCO Finland

Extensive body CT

9.5

274.2

648

1031

ZXE20

NOMESCO Finland

More than three and less than five hours

8.5

273.1

708

1310

UJF32

NOMESCO Finland

Coloscopy

6.5

267.7

962

2807

L01BC06

ATC

capecitabine; oral

19.5

257.9

408

270

R4110

NOMESCO Finland

Physiotherapy

6.2

257.6

972

2973

JN3BD

NOMESCO Finland

Extensive abdominal CT

8.9

242.2

589

954

130

Kela drug reimbursment

Malignant tumour

9.2

240.5

568

875

TPH07

NOMESCO Finland

Cathetrisation of artery

8.7

233.1

571

928

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

37.2

226.0

292

ZXD05

NOMESCO Finland

Urgent procedure

5.4

220.5

945

3175

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

12.9

216.7

410

407

A03FA01

ATC

metoclopramide; systemic, rectal

5.9

212.0

754

2015

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

234.9

204.3

207

ZXE10

NOMESCO Finland

More than one and less than three hours

4.8

200.0

1052

4244

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

181.9

188.0

194

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

6.0

179.6

587

1362

JG1CG

NOMESCO Finland

Extensive MRI of rectum

92.7

178.7

197

TPH04

NOMESCO Finland

Cathetrisation of vein

5.1

175.6

708

2085

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

9.9

170.3

368

458

WX402

NOMESCO Finland

General anaesthesia

5.4

170.2

618

1609

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

125.5

168.8

180

TJF80

NOMESCO Finland

Ostomy education

46.8

162.1

199

ZXE30

NOMESCO Finland

More than five and less than seven hours

11.0

161.4

327

358

JAH00

NOMESCO Finland

Laparotomy

17.0

158.6

261

179

WX600

NOMESCO Finland

Single shot through catheter

37.6

157.8

203

Z3231

NOMESCO Finland

Registered nurse

4.2

155.7

818

3044

ZXD10

NOMESCO Finland

Scheduled procedure

4.0

155.7

1012

4556

ZXE00

NOMESCO Finland

One hour or less

3.9

154.7

989

4378

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

13.3

153.5

281

248

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

13.8

153.0

275

233

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

6.5

151.3

444

872

WF001

NOMESCO Finland

Preoperative radiotherapy

37.3

149.8

193

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

10.5

145.9

302

341

H02AB02

ATC

dexamethasone; systemic

6.0

142.4

444

935

WX404

NOMESCO Finland

Intravenous generell anesthesy

4.3

137.3

648

2125

Z93.5

ICD-10 Finland

Cystostomy status

362.1

135.7

135

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

107.0

135.4

147

A04AA02

ATC

granisetron; systemic, transdermal

7.8

130.6

325

496

N02AA05

ATC

oxycodone; systemic

4.7

129.1

517

1427

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

202.3

127.5

131

N03AX16

ATC

pregabalin; oral

3.9

124.1

660

2364

JFF10

NOMESCO Finland

Loop enterostomy

72.9

123.8

141

ZX120

NOMESCO Finland

Intravenous

6.0

122.0

378

775

Z93

ICD-10 Finland

Artificial opening status

153.4

122.0

128

SPAT1125

SPAT

Stoma care and guidance

22.8

121.7

179

JN3AD

NOMESCO Finland

Abdominal CT examination

6.8

117.7

326

575

TQW40

NOMESCO Finland

Remowal of suture of skin

6.7

115.6

320

563

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

71.3

115.6

132

WX892

NOMESCO Finland

Monitored bed care

6.3

113.0

329

618

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

9.4

112.4

245

297

J01MA02

ATC

ciprofloxacin; systemic

3.2

110.5

927

4612

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

8.1

109.9

265

379

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.1

108.7

985

5151

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

13.9

107.1

190

152

Z93.1

ICD-10 Finland

Gastrostomy status

556.2

106.9

105

SPAT1262

SPAT

Handing over of treatment supplies

3.9

105.4

539

1819

D18

ICPC

Change in faeces/bowel movements

15.1

105.2

180

132

Z2221

NOMESCO Finland

Medical doctor

3.3

101.6

710

3046

TKC20

NOMESCO Finland

Catheterisation of bladder

5.9

101.2

311

620

WX002

NOMESCO Finland

Sedation and analgesia

3.7

100.1

549

1950

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

20.6

99.5

151

XF400

NOMESCO Finland

ECG with 12 standard connections

3.8

98.2

505

1697

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.8

97.5

368

924

Z3226

NOMESCO Finland

Physiotherapist

3.6

94.7

534

1926

P01AB01

ATC

metronidazole; oral, rectal

2.9

94.4

843

4221

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

7.8

92.7

226

325

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

33.6

92.7

122

ZX090

NOMESCO Finland

Other technic of radiotherapy

9.9

91.7

193

217

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

5.0

91.0

327

774

WZC30

NOMESCO Finland

Teaching

4.0

90.6

419

1271

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

62.0

90.1

105

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

6.1

89.9

266

501

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

14.7

89.9

155

115

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

75.6

88.3

100

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

6.2

87.7

256

473

R4190

NOMESCO Finland

Nutritional therapy

8.5

87.6

201

262

N02BE01

ATC

paracetamol; systemic, rectal

4.2

87.1

1570

12188

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

7.2

86.2

223

349

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

18.1

85.9

136

K56.7

ICD-10 Finland

Ileus, unspecified

14.9

84.0

144

105

JG1BG

NOMESCO Finland

MRI of rectum

34.8

82.9

108

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.9

82.4

389

1191

B01AB10

ATC

tinzaparin; parenteral

5.3

81.9

271

581

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

12.2

81.2

152

135

Z96.1

ICD-10 Finland

Presence of intraocular lens

12.3

80.5

150

132

ZXE40

NOMESCO Finland

More than seven and less than nine hours

13.6

80.3

143

114

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

26.9

79.7

111

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

68.5

79.3

K51.5

ICD-10 Finland

Left sided colitis

11.3

79.2

154

148

A28

ICPC

Limited function/disability NOS

3.6

78.6

424

1443

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

7.0

78.1

205

326

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

10.4

78.1

159

167

TJD20

NOMESCO Finland

Change of gastrostomy tube

51.6

77.4

Z93.6

ICD-10 Finland

Other artificial openings of urinary tract status

781.9

76.9

JFB00

NOMESCO Finland

Partial resection of small intestine

16.3

76.5

126

L04AX01

ATC

azathioprine; systemic

7.9

76.5

184

257

A04AA01

ATC

ondansetron; systemic, rectal

5.6

76.2

241

488

Z71.8

ICD-10 Finland

Other specified counselling

3.0

75.6

550

2319

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

6.2

75.6

217

389

JFH10

NOMESCO Finland

Total colectomy and ileostomy

121.3

75.6

Z93.0

ICD-10 Finland

Tracheostomy status

+∞

75.6

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

15.7

75.4

126

C20

ICD-10 Finland

Malignant neoplasm of rectum

23.0

74.1

108

JN4AD

NOMESCO Finland

Body CT examination

4.7

74.1

278

679

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

9.4

74.0

159

184

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

20.7

73.7

111

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

14.7

72.9

125

Z51.5

ICD-10 Finland

Palliative care

5.1

72.7

251

560

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.7

72.5

719

3656

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

13.0

72.4

131

108

Z93.4

ICD-10 Finland

Other artificial openings of gastrointestinal tract status

+∞

71.3

Z93.8

ICD-10 Finland

Other artificial opening status

+∞

71.3

WX110

NOMESCO Finland

Local anesthesy

2.6

70.6

1252

8707

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.3

70.3

416

1507

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.6

69.9

725

3764

A07EC02

ATC

mesalazine; oral, rectal

5.7

69.8

215

420

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

23.5

69.2

100

JDB10

NOMESCO Finland

Percutaneous gastrostomy

16.8

69.0

112

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

14.9

68.6

117

Z2446

NOMESCO Finland

Social worker

5.0

67.8

237

534

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.4

67.6

374

1283

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.6

66.5

632

3098

N02AX02

ATC

tramadol; systemic, rectal

2.4

66.1

851

4916

A02BC02

ATC

pantoprazole; systemic

2.5

65.8

1197

8254

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

40.9

65.4

TQW11

NOMESCO Finland

Vacuum treatment of wound

12.9

64.4

117

JFF13

NOMESCO Finland

Terminal enterostomy

60.2

64.2

Z43.5

ICD-10 Finland

Attention to cystostomy

38.6

63.8

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.0

63.1

425

1672

R33

ICD-10 Finland

Retention of urine

4.2

62.9

265

718

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

14.6

62.3

107

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

53.6

60.5

S18

ICPC

Laceration/cut

2.3

60.4

836

4932

D75

ICPC

Malignant neoplasm colon/rectum

23.4

60.2

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

10.2

59.8

122

128

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

19.0

59.5

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

3.2

58.4

346

1236

J01MA12

ATC

levofloxacin; systemic

2.9

58.1

437

1831

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

4.9

57.9

204

461

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

6.4

57.6

159

268

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

7.3

57.2

143

210

R50.9

ICD-10 Finland

Fever, unspecified

3.2

56.7

347

1266

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

34.6

56.2

J01DB01

ATC

cefalexin; oral

2.6

56.0

1437

11282

K50.8

ICD-10 Finland

Other Crohn disease

14.8

55.2

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

555.0

54.9

UKC02

NOMESCO Finland

Cystoscopy

2.8

54.3

405

1681

K65.0

ICD-10 Finland

Acute peritonitis

15.6

53.5

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

12.6

53.2

K50.9

ICD-10 Finland

Crohn disease, unspecified

14.1

52.4

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

18.2

52.4

WX306

NOMESCO Finland

Lumbar epidural anesthesy

5.2

52.1

172

360

UJG02

NOMESCO Finland

Proctoscopy

8.3

51.0

117

150

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

9.4

50.5

107

120

K51.8

ICD-10 Finland

Other ulcerative colitis

14.3

50.0

R11

ICD-10 Finland

Nausea and vomiting

4.0

49.9

218

604

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

28.2

49.8

A07EA02

ATC

hydrocortisone; rectal

8.7

49.8

111

136

A07EA06

ATC

budesonide; oral, local oral

7.2

49.5

125

186

K50.1

ICD-10 Finland

Crohn disease of large intestine

16.4

49.2

ZX095

NOMESCO Finland

Combined chemoradiotherapy

19.5

49.1

JN2BD

NOMESCO Finland

Extensive CT exmaniation of lower part of abdomen

54.5

49.0

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

19.8

48.7

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.0

48.6

327

1260

JAH01

NOMESCO Finland

Laparoscopy

6.0

48.4

141

254

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

13.5

48.2

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

11.7

48.1

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

9.2

47.5

102

117

KA1AE

NOMESCO Finland

Kidney ultrasound examination

8.6

47.5

106

130

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

14.9

47.4

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

11.7

46.6

1XC07

NOMESCO Finland

42.1

45.9

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

14.2

45.9

JHA00

NOMESCO Finland

Anal or perianal incision

13.7

45.2

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

85.8

45.1

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

14.0

45.1

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.6

44.9

137

261

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

4.8

44.3

157

354

UJF30

NOMESCO Finland

Ileoscopy through colon

3.3

44.2

244

815

L89

ICD-10 Finland

Decubitus ulcer and pressure area

9.4

43.5

103

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

30.0

43.3

GBB00

NOMESCO Finland

Tracheostomy

12.1

42.7

S97

ICPC

Chronic ulcer skin

4.4

42.6

164

402

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

42.6

619

3563

E0000UV

ATC

2.1

42.1

718

4415

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.4

41.8

222

719

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

10.4

41.7

D99

ICPC

Disease digestive system other

14.5

41.6

ZXA00

NOMESCO Finland

Right side

2.2

41.1

535

2922

E86

ICD-10 Finland

Volume depletion

7.5

41.0

100

141

XF600

NOMESCO Finland

Bloodpressure measurement

3.9

40.5

181

509

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

15.4

40.4

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

6.3

39.7

109

182

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

35.0

39.6

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.6

39.5

344

1533

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

59.0

39.4

K50.0

ICD-10 Finland

Crohn disease of small intestine

9.8

39.4

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

39.0

476

2512

WX882

NOMESCO Finland

High dependency care

5.7

38.9

117

219

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

139.9

38.9

A04AD12

ATC

aprepitant; systemic

8.0

38.7

118

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

8.8

38.3

100

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

4.0

38.3

161

428

Z97.4

ICD-10 Finland

Presence of external hearing-aid

199.3

37.9

JFG36

NOMESCO Finland

Closure of terminal colostomy with anastomosis to rectum

199.3

37.9

JFG30

NOMESCO Finland

Closure of colostomy with resection of exteriorised loop

104.9

37.9

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.5

37.8

193

604

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.6

37.7

184

556

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

8.1

37.7

113

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

5.4

37.5

118

233

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

14.8

37.4

ZXA05

NOMESCO Finland

Left side

2.2

37.3

505

2784

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

4.1

37.1

153

400

TPX10

NOMESCO Finland

Implantation of vascular injection port

6.0

37.0

106

187

A06AD11

ATC

lactulose; oral

2.6

36.8

316

1391

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

6.9

36.8

142

JFB46

NOMESCO Finland

Resection of sigmoid colon

12.2

36.0

WW500

NOMESCO Finland

Blood transfusion

4.8

35.8

125

277

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

10.7

35.8

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

9.6

35.7

A06AC01

ATC

ispaghula (psylla seeds); oral

2.2

35.7

457

2451

JGB36

NOMESCO Finland

Wide excision of rectum

53.7

35.5

JFF27

NOMESCO Finland

Laparoscopic sigmoidostomy

53.7

35.5

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

4.3

35.3

139

347

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

7.7

35.1

112

JEA00

NOMESCO Finland

Appendectomy

3.8

34.6

156

440

3AC01

NOMESCO Finland

17.9

34.6

WX872

NOMESCO Finland

Intensive care

4.6

34.5

126

292

WF049

NOMESCO Finland

Radiotherapy of metastasis

4.9

34.5

117

251

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

19.8

34.5

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.3

34.3

133

327

TK800

NOMESCO Finland

Hemodialysis

9.1

34.3

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.8

34.2

251

1005

JFG29

NOMESCO Finland

Closure of terminal enterostomy with anastomosis to rectum

343.7

34.0

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

4.6

33.9

122

279

127

Kela drug reimbursment

Transplant complication

178.5

33.8

R52.0

ICD-10 Finland

Acute pain

5.9

33.7

172

K92.1

ICD-10 Finland

Melaena

3.8

33.2

148

414

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

11.9

33.0

QB3S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in abdomen

91.9

32.8

D94

ICPC

Chronic enteritis/ulcerative colitis

18.1

32.8

UJH02

NOMESCO Finland

Anoscopy

4.3

32.8

127

312

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

173.3

32.8

C03CA01

ATC

furosemide; systemic

2.0

32.7

502

2886

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

23.0

32.7

N30.0

ICD-10 Finland

Acute cystitis

2.6

32.7

269

1149

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.3

32.6

174

562

D29

ICPC

Digestive symptom/complaint other

7.7

32.5

104

JFB43

NOMESCO Finland

Left hemicolectomy

16.7

32.5

A41.9

ICD-10 Finland

Sepsis, unspecified

4.7

32.2

113

252

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

4.9

32.0

108

231

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.0

31.5

105

221

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

20.1

31.4

JFF26

NOMESCO Finland

Sigmoidostomy

53.9

31.4

Z93.9

ICD-10 Finland

Artificial opening status, unspecified

+∞

31.3

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

5.6

31.3

176

128

Kela drug reimbursment

Cancers of female genital organs

9.7

31.2

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.6

31.2

255

1086

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

4.5

30.8

113

263

K43.5

ICD-10 Finland

Parastomal hernia without obstruction or gangrene

162.9

30.8

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

16.8

30.7

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(36304419) Bacteria [Presence] in Urine

1217

4427

5.68

314.67

5.5

3.0

—

(3002582) Erythrocytes [#/volume] in Urine

1284

4905

5.77

312.21

5.8

3.1

e6/l

60.3

72.4

0.35

1120

3745

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1574

7192

7.26

308.14

7.1

3.9

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

492

634

10.05

307.65

7.1

3.4

u/ml

352.8

2209.8

0.62

447

545

(3033658) Prothrombin time (PT) actual/Normal

1239

4112

6.56

307.65

10.3

3.9

88.1

88.9

0.47

1226

4024

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

854

1500

9.37

307.65

3.2

2.3

u/l

29.4

68.8

0.67

817

1283

(3042936) Bacteria identified in Isolate by Culture

871

2141

6.56

307.65

3.4

1.9

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

870

1769

8.09

307.65

4.0

2.6

umol/l

7.6

8.7

0.58

803

1556

(3024561) Albumin [Mass/volume] in Serum or Plasma

1620

6881

9.15

307.65

18.3

4.6

g/l

31.4

35.3

100.53

1584

6376

(3023368) Bacteria identified in Blood by Culture

1309

4423

7.01

307.65

9.6

4.1

—

(3044640) Blood type and Crossmatch panel - Blood

1381

4884

7.32

307.65

5.1

2.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

943

1698

9.85

307.65

9.2

4.1

ug/l

13.4

23.5

0.92

829

1419

(3030467) Casts [#/volume] in Urine by Automated count

1247

4518

5.91

307.65

5.5

3.0

e6/l

0.6

0.4

0.56

1076

3396

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1204

3759

6.79

307.65

4.4

2.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1663

8187

8.16

292.76

15.5

6.1

umol/l

11.2

12.3

2.34

1631

7766

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1385

5850

5.76

291.65

5.8

3.1

—

(3032080) INR in Blood by Coagulation assay

1430

6308

5.80

282.23

10.3

8.2

inr

1.2

1.3

1.18

302

1685

(3026782) Osmolality of Urine

966

3125

5.16

281.52

4.5

2.5

mosm/kgh2o

530.4

564.7

5.48

856

2634

(3000850) Epithelial cells [#/volume] in Urine

1008

3374

5.13

281.51

4.2

2.4

e6/l

5.1

0.01

896

2951

(3018095) Leukocytes [#/volume] in Urine

1336

5689

5.32

272.21

6.9

3.5

e6/l

176.2

103.8

1.25

1145

4020

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

537

1069

6.56

271.40

2.3

1.6

—

(40758558) Short blood count panel - Blood

1103

4078

4.94

268.60

15.6

6.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

838

2516

5.10

265.21

8.0

3.1

mmol/l

0.8

10.08

807

2350

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

368

527

8.38

252.50

5.3

3.1

u/ml

0.2

0.4

9.29

207

300

(3007853) Bacteria identified in Skin by Aerobe culture

680

1783

5.33

251.89

2.7

1.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

622

1519

5.55

250.14

3.6

2.2

g/l

0.2

0.39

593

1420

(3000991) Gas panel - Venous blood

604

1453

5.58

246.80

13.0

7.9

—

(3020779) Urea [Moles/volume] in Serum or Plasma

589

1395

5.62

244.80

9.6

5.3

mmol/l

9.1

9.4

0.57

569

1322

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

832

2638

4.77

242.35

4.4

2.9

e6/l

2.6

2.1

0.69

529

1436

(3014111) Lactate [Moles/volume] in Serum or Plasma

611

1512

5.44

241.14

10.4

7.3

mmol/l

1.3

1.4

1.11

584

1460

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

846

2851

4.48

224.60

4.1

2.7

e6/l

1.3

1.1

0.53

538

1634

(3026008) Bacteria identified in Urine by Culture

1100

4555

4.26

218.12

5.5

3.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1154

4946

4.28

217.84

5.1

3.2

u/l

32.0

35.7

1.23

1120

4708

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1126

4804

4.20

212.46

3.7

2.5

u/l

56.3

57.1

0.31

1087

4418

(3003458) Phosphate [Moles/volume] in Serum or Plasma

696

2121

4.55

209.02

9.6

4.7

mmol/l

1.0

0.15

664

1958

(3022145) Colonoscopy Study observation

598

1657

4.77

202.26

1.9

1.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1621

9179

5.62

202.19

20.7

9.0

e9/l

4.5

4.1

6.07

1478

7877

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

411

880

5.66

187.69

6.9

4.5

mmol/l

23.7

24.1

1.23

393

781

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

823

3043

3.96

185.66

9.3

3.1

mmol/l

2.5

9.88

759

2661

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

611

1864

4.32

179.98

14.0

7.3

kpa

5.2

5.1

0.50

592

1773

(3027801) Oxygen [Partial pressure] in Arterial blood

611

1865

4.32

179.84

14.0

7.3

kpa

13.4

12.1

6.18

592

1773

(3003396) Base excess in Arterial blood by calculation

609

1859

4.31

179.16

14.1

7.3

mmol/l

0.8

1.1

1.06

521

1451

(3031040) Bacteria [#/volume] in Urine by Automated count

1679

10287

5.65

175.62

8.5

4.2

e6/l

833.5

1249.6

0.25

171

(3015377) Calcium [Moles/volume] in Serum or Plasma

1126

5374

3.60

167.55

10.0

3.3

mmol/l

2.3

2.4

4.15

1055

4661

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1354

7389

3.75

160.26

14.7

5.9

mmol/l

1.2

16.80

1311

6681

(3002173) Hemoglobin [Mass/volume] in Arterial blood

525

1547

4.28

160.19

15.4

8.1

g/l

113.9

122.0

16.80

514

1482

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

177

175

11.03

160.00

9.7

6.5

mg/l

12.5

11.4

1.40

161

163

(3021447) Carbon dioxide [Partial pressure] in Venous blood

536

1606

4.23

159.84

6.9

3.9

kpa

5.9

5.8

0.99

514

1556

(3016502) Oxygen saturation in Arterial blood

547

1668

4.17

159.17

15.2

7.7

96.5

95.4

4.52

533

1594

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

376

857

5.20

158.44

13.2

9.8

mmol/l

24.2

24.5

0.60

360

805

(3002032) Base excess in Venous blood by calculation

531

1597

4.20

157.30

6.9

3.9

mmol/l

1.8

1.9

0.13

435

1244

(3022948) Iron [Moles/volume] in Serum or Plasma

664

2348

3.78

155.72

3.3

2.3

umol/l

10.3

13.2

18.59

642

2177

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

604

2025

3.88

152.93

3.3

2.3

18.2

23.2

14.36

558

1738

(40768804) Tissue Pathology biopsy report

1204

6227

3.45

152.61

3.3

2.1

—

(3018418) pH of Serum or Plasma

1020

4798

3.37

150.87

7.0

3.7

7.4

0.02

153

831

(3013826) Glucose [Moles/volume] in Serum or Plasma

1531

9305

4.04

147.82

11.7

4.6

mmol/l

6.8

0.01

1490

8722

(3004789) Transferrin [Mass/volume] in Serum or Plasma

619

2162

3.73

146.75

3.3

2.2

g/l

2.2

2.3

2.52

599

2003

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1395

8050

3.60

144.64

14.3

6.4

mmol/l

1.2

17.71

1259

6852

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1780

12159

6.53

143.75

19.8

7.1

u/l

93.0

80.9

13.30

1743

11414

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

888

3934

3.32

143.45

3.2

2.2

mg/l

3.4

3.0

3.43

791

3334

(42870588) Differential panel, method unspecified - Blood

1080

5406

3.25

141.07

8.5

5.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

559

1883

3.76

139.05

2.2

1.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

246

427

6.45

138.45

4.1

3.1

g/l

3.7

3.6

0.56

238

405

(3002256) Pathology report gross observation

578

2014

3.66

136.32

1.4

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

556

1899

3.70

135.03

2.2

1.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

630

2346

3.49

133.65

3.8

2.2

30.5

29.8

1.62

619

2272

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

665

2589

3.38

130.95

2.4

1.7

—

(3001604) Monocytes [#/volume] in Blood

1338

7808

3.29

130.08

9.3

5.8

e9/l

0.6

3.30

1145

6591

(3006315) Basophils [#/volume] in Blood

1338

7840

3.27

128.49

9.4

5.8

e9/l

0.0

3.09

1153

6632

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

350

893

4.56

127.01

17.6

9.8

—

(3019198) Lymphocytes [#/volume] in Blood

1355

8029

3.27

126.97

9.4

5.8

e9/l

1.7

2.0

3.64

1194

6934

(3013115) Eosinophils [#/volume] in Blood

1360

8110

3.26

125.32

10.0

6.1

e9/l

0.2

0.95

1198

6998

(3022096) Basophils/100 leukocytes in Blood

1248

7133

3.10

123.08

9.7

6.0

0.6

0.7

11.63

1180

6642

(3019069) Monocytes/100 leukocytes in Blood

1272

7356

3.11

122.66

9.9

6.3

8.8

0.18

1205

6867

(3006504) Eosinophils/100 leukocytes in Blood

1263

7327

3.07

120.08

9.7

6.0

2.5

2.9

5.97

1192

6822

(3002030) Lymphocytes/100 leukocytes in Blood

1285

7539

3.08

119.44

9.7

6.1

22.7

28.1

47.53

1213

7016

(3018010) Neutrophils/100 leukocytes in Blood

1269

7411

3.05

118.61

9.4

5.9

61.8

56.8

32.85

1199

6922

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

228

447

5.65

112.40

1.6

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

236

489

5.36

109.34

6.3

3.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1580

10742

3.52

107.68

7.2

4.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

217

423

5.65

107.52

2.9

3.0

216.4

187.6

4.07

210

403

(3021589) Normoblasts [#/volume] in Blood

1181

6937

2.79

103.62

18.9

9.2

e9/l

0.0

1.00

949

5542

(4035726)

414

1392

3.51

100.21

1.5

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

682

3075

2.88

99.49

5.1

3.5

ng/l

374.9

383.9

0.02

584

2482

(3051651) Icteric interference index of Serum or Plasma

101

11.78

97.36

7.0

3.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

402

1360

3.47

96.06

5.8

3.6

kpa

5.0

4.6

2.01

376

1319

(3036489) Thrombin time

243

576

4.68

95.62

3.2

2.5

22.3

21.6

0.65

231

516

(3044889) 12 lead EKG panel

1587

11190

3.28

93.75

5.1

3.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1068

6196

2.61

92.24

4.1

2.6

ug/l

146.5

144.0

0.11

1008

5680

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

181

358

5.47

87.88

1.6

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

181

358

5.47

87.88

1.6

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

118

154

8.09

85.61

6.7

3.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1067

6547

2.40

76.48

2.6

2.0

pmol/l

85.5

93.8

7.57

656

3384

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

181

413

4.73

74.17

2.2

1.7

—

(3002385) Erythrocyte distribution width [Ratio]

1693

13005

3.35

74.03

62.8

17.2

14.7

13.7

86.14

1682

12711

(3037121) Protein [Mass/volume] in Urine

211

555

4.14

71.95

5.8

3.4

g/l

0.3

0.01

176

236

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1880

15667

7.17

68.96

53.3

13.7

mg/l

42.2

25.7

82.29

1829

12257

(3027945) Reticulocytes/100 erythrocytes in Blood

442

1904

2.71

66.87

2.7

1.8

0.38

401

1691

(3025941) Bacteria identified in Stool by Culture

247

765

3.55

66.39

1.5

1.3

—

(3024928) Oxygen saturation in Venous blood

158

354

4.77

66.06

4.5

4.7

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

11.32

65.27

4.7

2.3

umol/l

2.2

1.8

2.10

(3003694) ABO and Rh group [Type] in Blood

751

4169

2.31

65.12

1.5

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

274

930

3.27

63.56

1.6

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

132

263

5.31

63.25

5.4

2.6

iu/ml

853.0

1381.2

0.29

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

169

416

4.35

62.73

7.0

4.8

mg/l

1.7

1.4

3.60

159

376

(3009542) Hematocrit [Volume Fraction] of Blood

1759

14209

3.51

62.60

57.2

15.4

36.9

39.7

51.55

1351

9971

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

624

3250

2.36

62.30

2.6

1.7

mg/l

2.5

1.4

3.24

532

2512

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

367

1508

2.77

60.35

7.3

3.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

333

1302

2.88

60.14

3.0

2.5

ng/l

227.3

175.6

1.39

296

1180

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

15.11

59.78

3.3

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

351

1445

2.74

57.29

1.7

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

410

1852

2.54

55.29

3.7

4.0

u/l

241.9

250.7

0.37

394

1750

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

131

291

4.75

55.22

1.6

1.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

170

463

3.93

54.91

1.4

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

168

455

3.95

54.69

1.4

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

271

995

3.00

54.58

2.0

1.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

170

469

3.88

53.90

1.4

1.1

—

(3019060) Gas panel - Arterial blood

280

1059

2.92

53.40

12.7

4.5

—

(3048689) Calprotectin [Mass/mass] in Stool

386

1721

2.55

53.33

3.5

2.3

ug/g

268.5

137.4

4.93

330

1392

(3011397) Hemoglobin [Presence] in Urine by Test strip

665

3767

2.16

52.47

4.7

3.5

—

(3003338) MCHC [Mass/volume]

1647

13341

2.54

48.58

64.9

18.4

g/l

328.0

332.7

70.12

1639

13232

(3019550) Sodium [Moles/volume] in Serum or Plasma

1879

16376

5.48

48.57

59.4

16.0

mmol/l

138.7

139.7

49.70

1862

15952

(3022217) INR in Platelet poor plasma by Coagulation assay

404

1916

2.40

48.39

28.9

22.4

inr

1.4

1.3

0.51

230

(3023103) Potassium [Moles/volume] in Serum or Plasma

1880

16417

5.48

47.88

59.3

16.1

mmol/l

3.9

4.0

6.07

1862

15967

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

196

642

3.28

47.73

3.4

1.8

ug/l

3.1

2.7

0.14

180

567

(3000494) Fungus identified in Specimen by Culture

380

1795

2.39

45.69

1.9

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

542

2968

2.15

45.56

2.0

1.7

nmol/l

1178.3

1199.1

0.16

423

2232

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

362

1680

2.42

45.25

1.8

1.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

285

1182

2.65

45.18

5.9

3.3

ng/l

113.9

83.0

2.42

263

1034

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

194

653

3.19

45.09

7.9

3.5

u/ml

86.9

71.3

0.23

189

627

(3021960) Folate [Moles/volume] in Serum or Plasma

634

3732

2.04

43.58

1.9

1.5

nmol/l

21.5

20.7

0.24

577

3167

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

922

6176

1.94

43.53

3.8

2.2

nmol/l

74.6

77.5

2.67

857

5478

(1616796) Gas panel - Central venous blood

124

318

4.10

43.38

5.5

3.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

157

476

3.50

43.13

10.0

4.9

kpa

8.5

8.6

0.27

148

440

(3021879) Hepatitis B virus core Ab [Presence] in Serum

239

948

2.73

41.20

1.5

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

201

728

2.96

41.05

1.7

1.8

g/l

1.8

1.6

3.06

178

623

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

134

378

3.73

40.99

1.4

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

1061

7570

1.88

40.09

7.4

4.7

estimate

0.0

0.50

205

1332

(3009261) Glucose [Presence] in Urine by Test strip

1066

7648

1.87

39.25

5.7

3.5

estimate

0.0

0.80

209

1269

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

740

4730

1.91

39.10

2.6

2.1

u/l

218.4

242.8

0.28

698

4445

(3035350) Ketones [Presence] in Urine by Test strip

1053

7555

1.86

38.46

5.7

3.5

estimate

0.0

0.00

198

1303

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1715

14623

2.47

37.08

47.7

13.0

ml/min/173m2

81.8

79.3

3.94

1593

11902

(3023183) Ammonium ion [Moles/volume] in Plasma

122

348

3.67

36.68

4.1

2.5

umol/l

34.7

36.0

0.24

104

297

(3008152) Bicarbonate [Moles/volume] in Arterial blood

241

1015

2.57

36.67

20.1

6.7

mmol/l

24.5

24.6

0.13

232

934

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

226

4.37

36.66

3.0

2.6

u/ml

4.4

23.7

0.58

217

(40761511) CBC panel - Blood by Automated count

1838

16242

3.44

36.66

42.2

12.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

190

712

2.85

36.35

1.4

1.3

—

(3021901) Oxygen saturation in Capillary blood

102

260

4.09

35.94

3.9

2.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

391

2051

2.13

35.69

1.9

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

131

413

3.33

33.74

1.3

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

123

373

3.45

33.69

6.4

3.0

mmol/l

24.4

25.3

1.25

112

322

(3015736) pH of Urine

854

5907

1.80

33.62

4.8

3.3

—

6.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

290

1381

2.29

33.48

2.7

2.3

nmol/l

365.3

367.0

0.04

273

1267

(3020891) Body temperature

177

672

2.80

32.97

11.6

4.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1858

16685

3.60

32.76

24.5

10.2

u/l

25.0

26.4

2.93

1833

16054

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

199

4.31

31.71

4.0

1.7

u/ml

728.7

1494.8

—

(40767503) Oxygen content in Capillary blood by calculation

104

297

3.64

31.19

3.6

2.3

16.2

16.3

0.02

142

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

276

1326

2.26

31.07

2.5

2.2

ug/l

5.1

6.5

0.93

242

1161

(3004119) Hemoglobin [Mass/volume] in Venous blood

229

1016

2.42

30.97

5.9

3.5

g/l

120.2

129.8

6.94

224

987

(3003181) Sodium [Moles/volume] in Urine

100

283

3.67

30.39

3.5

1.4

mmol/l

68.4

62.9

0.42

233

(3023520) Reticulocytes [#/volume] in Blood

287

1423

2.19

29.84

3.0

2.7

e9/l

68.7

69.6

0.16

204

1048

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

6.76

29.81

1.3

1.1

u/l

61.1

18.7

1.66

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

257

1229

2.26

29.17

3.6

2.5

ml/min/173m2

62.0

66.4

0.82

119

482

(3049717) Cytology report of Urine Cyto stain

168

664

2.67

28.88

3.0

2.7

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

6.40

28.31

1.3

1.1

u/l

162.5

90.0

1.12

(3013707) Erythrocyte sedimentation rate by Westergren method

1413

11621

1.79

27.91

4.8

3.9

mm/h

19.6

12.5

29.86

1332

10725

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

5.96

27.50

2.4

1.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

132

4.82

27.44

1.3

1.1

u/l

128.7

76.6

0.35

(3012501) Base excess in Blood by calculation

104

327

3.30

26.88

7.1

4.6

mmol/l

3.1

2.8

0.42

233

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

108

355

3.16

25.95

1.7

1.5

—

(3010421) pH of Blood

113

387

3.04

25.31

6.8

4.3

7.4

0.73

103

321

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

181

793

2.41

25.02

5.6

3.4

0.7

0.6

0.53

176

755

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

654

4466

1.70

24.99

3.4

2.6

ng/l

1728.0

1404.9

0.60

581

3806

(3006184) Hemoglobin [Mass/volume] in Capillary blood

104

343

3.15

24.85

2.9

2.0

g/l

127.4

130.9

0.53

232

(3007461) Platelets [#/volume] in Blood

1884

17420

3.68

24.37

71.0

20.5

e9/l

269.6

248.3

23.83

1856

16896

(3024731) MCV [Entitic volume]

1884

17423

3.68

24.30

70.7

20.4

91.0

91.1

0.50

1871

17136

(3035941) MCH [Entitic mass]

1884

17424

3.68

24.27

70.7

20.4

29.9

30.4

18.83

1871

17137

(3026361) Erythrocytes [#/volume] in Blood

1884

17426

3.67

24.23

71.0

20.5

e12/l

4.1

4.5

145.79

1854

16832

(3010813) Leukocytes [#/volume] in Blood

1884

17428

3.67

24.18

71.0

20.5

e9/l

7.4

6.7

24.28

1854

16835

(3000963) Hemoglobin [Mass/volume] in Blood

1884

17429

3.67

24.16

71.5

20.6

g/l

121.9

135.7

222.18

1870

17147

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

214

1032

2.21

23.60

10.3

3.9

mmol/l

1.9

1.7

0.29

161

755

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

103

349

3.06

23.50

1.8

1.5

—

(3028271) Lactate [Moles/volume] in Capillary blood

232

3.55

23.46

2.8

1.8

mmol/l

1.7

0.10

224

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

220

1078

2.17

23.31

10.7

4.0

kpa

5.2

5.1

0.46

212

1003

(3009343) pH of Capillary blood

218

1067

2.17

23.16

10.5

4.0

7.4

0.61

111

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

105

365

2.98

22.92

5.0

3.4

u/ml

56.3

1016.5

0.81

339

(3047181) Lactate [Moles/volume] in Blood

125

495

2.63

21.35

17.7

5.7

mmol/l

1.4

0.18

109

423

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

218

3.49

21.20

1.4

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

16.51

21.13

2.3

5.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

263

1427

1.98

21.09

2.6

2.7

g/l

64.8

66.6

2.53

238

1302

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1116

8951

1.58

20.88

2.9

2.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

5.28

20.36

2.0

1.5

u/l

5.1

5.5

0.04

(3042733) HLA Ab [Presence] in Serum

15.13

20.22

4.9

3.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

230

3.35

20.19

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

262

3.18

20.01

1.7

1.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1945

0.33

19.96

4.3

4.5

33.2

32.3

0.31

1243

(3007164) IgA [Mass/volume] in Serum or Plasma

445

2896

1.70

19.54

1.6

1.5

g/l

2.9

2.4

1.02

249

1683

(4281824)

146

3.92

19.17

1.3

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

111

438

2.63

19.10

1.6

1.5

ug/g

222.4

268.9

1.52

261

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

170

3.67

19.00

1.8

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1184

9745

1.55

18.81

5.3

3.0

u/l

75.8

51.5

6.01

1110

9029

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

226

3.27

18.69

1.8

1.5

—

(40768797) Stomach Pathology biopsy report

351

2187

1.74

17.90

1.4

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

100

389

2.66

17.71

1.3

1.2

titre

457.1

91.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

184

3.45

17.59

2.0

1.6

—

(3045788) Cell count panel - Pleural fluid

168

3.53

17.08

1.9

1.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

101

408

2.56

16.58

1.3

1.2

—

10.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

183

3.35

16.33

1.6

1.3

e6/l

15361.9

88641.2

1.21

102

(3018572) Chloride [Moles/volume] in Blood

353

2.66

16.22

22.4

6.4

mmol/l

106.3

105.5

0.78

304

(3039000) Anion gap in Blood

353

2.66

16.22

22.3

6.4

mmol/l

11.0

11.2

0.15

304

(3011648) Oxygen content in Venous blood

155

3.55

16.14

2.9

7.1

10.9

11.6

0.53

155

(3023199) Leukocytes [#/volume] in Pleural fluid

203

3.17

15.71

1.6

1.3

e6/l

4778.5

1849.4

0.46

142

(3012441) Differential panel - Pleural fluid

173

3.36

15.65

1.6

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

5.32

15.62

5.5

1.8

mg/l

100.8

81.8

0.39

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

7.85

15.30

1.2

2.0

ug/l

2.1

1.8

0.18

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

7.04

15.27

7.5

5.9

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

133

3.68

15.12

2.6

2.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

7.31

14.41

6.1

6.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

109

494

2.28

13.91

2.7

2.2

g/l

0.0

0.00

458

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

10.79

13.76

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

109

498

2.26

13.65

2.7

2.2

g/l

0.0

0.00

459

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

103

465

2.28

13.28

1.7

1.5

iu/ml

0.2

1.5

0.47

102

(3027273) Bicarbonate [Moles/volume] in Venous blood

149

783

1.98

12.96

5.8

2.9

mmol/l

24.6

25.0

0.64

141

755

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

111

524

2.19

12.85

2.6

2.2

g/l

0.1

0.0

0.13

483

(3003434) Protein [Mass/volume] in Pleural fluid

219

2.84

12.65

1.5

1.4

g/l

31.5

33.5

0.54

202

(40768441) Liver Pathology biopsy report

107

3.70

12.50

1.6

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

112

546

2.12

11.96

2.6

2.1

g/l

36.0

37.6

1.54

100

476

(3022313) Gas panel - Capillary blood

149

810

1.91

11.74

11.2

4.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

194

1145

1.77

11.74

3.4

2.5

g/l

10.5

10.4

0.13

180

1051

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

305

2.48

11.71

4.6

3.4

58.9

57.2

0.41

305

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

117

3.47

11.68

1.7

—

(1761868) Lipid panel - Serum or Plasma

363

5048

0.65

11.67

2.7

2.9

—

(3023419) Bacteria identified in Sputum by Culture

201

2.84

11.64

2.3

2.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

247

2.65

11.59

1.8

1.2

u/ml

119.3

121.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

123

629

2.02

11.56

2.5

2.3

g/l

3.3

3.2

0.91

104

506

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

314

2.44

11.49

1.8

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

124

638

2.01

11.46

2.5

2.3

g/l

10.5

10.2

0.34

106

547

(44806118)

182

2.91

11.32

1.8

1.4

—

(44790047)

182

2.91

11.32

1.8

1.4

—

(44790048)

182

2.91

11.32

1.8

1.4

—

(44790049)

182

2.91

11.32

1.8

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

160

908

1.83

11.03

2.3

1.9

g/l

1.1

1.5

1.73

148

831

(3007930) Methemoglobin/Hemoglobin.total in Blood

121

627

1.99

10.97

17.7

5.1

1.0

0.9

2.97

114

578

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

127

674

1.95

10.76

2.5

2.3

g/l

4.4

3.9

0.58

103

496

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

127

675

1.94

10.71

2.5

2.3

g/l

7.7

7.5

0.65

104

518

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

127

675

1.94

10.71

2.5

2.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

120

630

1.96

10.49

17.9

5.1

1.7

1.6

0.94

113

579

(3004588) Protein electrophoresis panel - Serum or Plasma

192

1171

1.71

10.33

2.3

2.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

439

3238

1.46

10.30

1.2

1.3

u/ml

1.4

1.8

0.27

795

(3001964) Herpes simplex virus Ag [Presence] in Specimen

5.63

10.23

1.8

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

377

2.23

10.18

1.8

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

128

3.17

10.18

1.2

titre

92.5

135.6

0.39

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

107

548

2.01

10.04

2.8

3.5

mg/l

47.7

75.3

0.58

451

(3030905) Polymorphonuclear cells [#/volume] in Blood

297

2.37

9.98

4.1

3.2

e9/l

4.5

4.2

0.33

297

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

231

2.56

9.90

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

104

531

2.01

9.85

2.8

3.5

—

1.9

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

250

2.49

9.82

1.7

1.2

u/ml

270.0

240.5

0.31

137

(4306422)

198

2.67

9.72

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

113

597

1.95

9.71

2.6

2.4

g/l

0.8

1.0

0.13

520

(3034860) Kappa light chains.free [Mass/volume] in Serum

106

548

1.99

9.70

2.9

3.5

mg/l

65.7

158.2

0.44

449

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

254

1692

1.58

9.62

2.0

1.8

1.6

1.5

1.12

213

1479

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

271

2.41

9.61

1.8

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

3.95

9.59

2.2

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

461

2.07

9.55

1.6

1.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

3.90

9.41

2.2

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

6.56

9.35

1.8

2.3

umol/l

14.6

19.0

0.64

(3018738) Hemoglobin F/Hemoglobin.total in Blood

8.62

9.35

4.7

2.2

5.0

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

218

2.52

9.00

1.2

u/ml

2.1

4.1

0.72

(40768806) Pleura Pathology biopsy report

177

2.70

8.99

1.4

1.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

9.21

8.98

10.5

15.1

mmol/l

4.8

5.7

0.56

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

201

2.58

8.93

1.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

176

1092

1.67

8.88

5.4

4.0

0.7

0.6

0.55

268

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

258

2.37

8.74

1.7

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

426

3211

1.42

8.72

6.8

4.5

—

(3002619) Bacteria identified in Specimen by Culture

5.35

8.69

1.6

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

103

550

1.92

8.61

2.2

2.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

267

2.33

8.54

1.7

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

136

795

1.76

8.52

3.5

3.3

pmol/l

4.1

4.5

3.60

121

690

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

6.88

8.44

6.7

7.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1539

14182

1.41

8.43

5.0

4.5

mu/l

2.1

0.19

1385

12838

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

195

2.55

8.43

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

263

2.32

8.38

3.3

2.2

u/l

402.3

2660.9

1.30

102

(3009214) Lutropin [Units/volume] in Serum or Plasma

351

2.12

8.16

1.4

1.5

u/l

10.4

8.5

0.61

272

(40768446) Kidney Pathology biopsy report

4.77

8.12

2.0

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

188

1217

1.60

8.02

5.7

4.2

1.0

0.8

0.38

378

(3029937) Albumin [Presence] in Urine by Test strip

517

4096

1.36

7.71

7.6

3.9

estimate

0.0

0.31

183

1256

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

210

2.42

7.70

1.2

u/ml

2.8

5.1

1.14

(40761536) Microorganisms panel - Urine sediment

187

1226

1.58

7.56

9.2

3.5

—

(3037522) Nuclear Ab [Titer] in Serum

271

1929

1.47

7.47

1.4

1.3

titre

305.1

459.8

2.05

402

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

709

5913

1.31

7.37

4.9

3.3

ng/l

37.2

47.3

0.63

552

4184

(3024980) IgG subclass 4 [Mass/volume] in Serum

229

2.31

7.23

1.5

1.7

g/l

1.0

0.9

0.10

181

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

5.03

7.18

4.0

3.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

236

2.28

7.18

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

145

2.65

7.15

1.3

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

406

1.96

7.07

2.6

3.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

3.41

6.98

1.3

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

509

1.85

6.95

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

227

2.28

6.93

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

114

2.84

6.85

3.1

2.5

umol/l

19.8

10.8

0.27

(3033799) Differential panel - Peritoneal fluid

3.91

6.71

2.4

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

206

2.31

6.63

1.6

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

4.17

6.55

2.0

2.1

—

(3028707) Methadone [Presence] in Urine by Screen method

152

2.53

6.53

3.6

2.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

208

2.29

6.49

1.4

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

294

2.07

6.45

3.2

3.3

nmol/l

0.8

0.19

244

(3026493) Urate [Moles/volume] in Serum or Plasma

512

4153

1.32

6.32

3.5

2.6

umol/l

3802.6

6325.8

0.62

431

3590

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

3.27

6.28

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

238

2.17

6.22

5.1

2.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

3.68

6.20

1.3

2.0

e6/l

49331.9

2705.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

104

2.82

6.16

3.3

1.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

180

1228

1.51

6.11

7.4

3.7

mmol/l

1.2

2.37

168

1066

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

119

737

1.65

6.10

6.3

3.5

50.0

49.9

0.02

114

730

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.31

6.02

1.3

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

4.31

6.02

1.6

1.5

—

(3025159) Blasts/100 leukocytes in Blood

162

1085

1.54

5.99

5.7

4.4

0.0

0.1

1.53

291

(3052592) Norovirus Ag [Presence] in Stool

4.84

5.97

2.8

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

170

1154

1.52

5.91

5.9

4.2

0.1

0.04

345

(3035320) C reactive protein [Mass/volume] in Body fluid

118

2.65

5.91

3.0

2.3

—

(3008295) Osmolality of Serum or Plasma

173

2.34

5.85

2.1

1.4

mosm/kgh2o

279.7

280.8

0.10

123

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

128

817

1.61

5.83

2.4

2.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

408

1.85

5.71

1.9

1.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

401

1.85

5.70

1.6

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

432

1.81

5.62

1.6

1.4

iu/l

25.9

28.0

0.23

353

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

12.91

5.58

1.7

1.4

—

(3014891) Appearance of Pleural fluid

5.26

5.52

1.9

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

3.08

5.50

1.2

1.3

nmol/l

133.0

147.3

0.53

(3044007) Cell count panel - Peritoneal fluid

3.64

5.48

1.1

2.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

2.79

5.47

2.3

1.4

g/l

0.8

1.0

1.25

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

106

2.67

5.41

2.6

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

254

2.04

5.31

3.6

3.2

1.3

1.7

0.28

196

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.00

5.26

1.1

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

114

2.57

5.22

1.5

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

2.68

5.08

1.4

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.79

4.88

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.79

4.88

1.1

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

143

2.33

4.85

1.2

1.1

—

(40761535) Cells panel - Urine sediment

190

1373

1.43

4.83

5.8

3.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

11.47

4.78

1.4

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

11.47

4.78

3.4

3.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

152

2.26

4.67

1.7

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

172

2.17

4.63

1.8

1.4

—

(3000012) Reticulocyte production index

2.69

4.58

1.3

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

128

2.36

4.58

1.5

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

128

2.36

4.58

1.5

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

128

2.36

4.58

1.5

1.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

116

2.43

4.56

1.9

2.4

17.5

13.0

0.68

(3014148) Varicella zoster virus Ab [Titer] in Serum

116

2.43

4.56

1.3

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.74

4.52

1.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

117

2.41

4.48

2.0

2.5

—

(40768443) Skin Pathology biopsy report

102

660

1.58

4.45

1.3

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.70

4.42

1.7

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

3.02

4.40

1.2

2.0

e6/l

845.4

669.8

—

(3009508) Creatinine [Moles/volume] in Urine

594

5096

1.24

4.39

3.6

3.1

mmol/l

7.6

0.12

499

4281

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.57

4.39

1.6

—

(3013336) Amino acids [Identifier] in Serum or Plasma

7.53

4.35

2.3

2.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

2.90

4.33

2.0

2.5

23.5

12.4

1.28

(1175426) CD3 cells/100 lymphocytes in Blood

119

2.37

4.33

2.0

2.4

63.6

71.2

1.04

113

(3025130) Human papilloma virus identified in Specimen

119

2.37

4.33

1.4

1.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.35

4.32

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.56

4.30

1.5

1.0

—

(36660697) Celiac disease serology panel - Serum

167

1206

1.42

4.28

1.1

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

8.92

4.28

3.8

3.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

11.70

4.27

1.9

1.7

—

(3000492) Spirometry study

189

1397

1.39

4.24

1.6

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

663

5772

1.23

4.23

6.7

3.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.64

4.23

1.1

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

391

1.71

4.09

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.37

4.09

1.5

1.0

—

(3011412) CD3 cells [#/volume] in Blood

142

2.20

4.06

1.8

2.4

e9/l

1.0

1.2

0.44

(3014051) Protein [Presence] in Urine by Test strip

363

1.73

4.01

2.7

2.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

3.95

3.98

1.5

2.0

ng/l

95.3

122.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

2.49

3.97

1.4

1.1

—

(3019150) Specific gravity of Urine by Refractometry

410

3416

1.25

3.89

6.2

4.0

kg/l

1.0

0.26

484

(3027570) Oxalate [Moles/time] in 24 hour Urine

7.30

3.86

1.0

1.5

umol/24h

336.0

381.5

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

12.03

3.76

1.5

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

121

2.25

3.74

1.0

1.2

u/ml

—

(3021788) Differential panel - Synovial fluid

282

1.79

3.70

1.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

5.65

3.66

1.2

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1245

11611

1.20

3.64

4.3

3.8

pmol/l

14.7

14.9

0.78

1124

10477

(3004451) EKG impression Narrative

2.55

3.63

1.8

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.87

3.63

1.8

2.0

umol/l

53.9

84.3

—

(3000060) B lymphocytes [#/volume] in Blood

2.96

3.57

1.9

2.2

e6/l

483.0

317.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

234

1.86

3.57

6.3

4.8

umol/l

355.4

345.4

0.14

205

(3045414) Leukocytes [Presence] in Urine

655

1.51

3.55

2.7

1.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

105

2.30

3.52

2.0

1.4

promille

1.1

1.3

0.24

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.82

3.52

1.4

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.82

3.52

1.4

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.82

3.52

1.4

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.82

3.52

1.4

1.5

—

(3035880) pH of Pleural fluid

2.34

3.50

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

358

1.67

3.40

1.7

1.6

mu/l

287.2

0.00

327

(21494755) Public health laboratory ask at order entry panel

1121

0.65

3.39

1.2

1.4

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.51

3.38

2.3

1.8

u/ml

1555.1

1218.2

0.27

(40757494) Bilirubin.total [Moles/volume] in Blood

102

2.27

3.29

5.0

2.1

umol/l

35.9

70.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.31

3.27

1.5

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.31

3.27

1.5

1.9

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.79

3.25

1.1

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

3.04

3.25

2.5

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

350

0.40

3.20

7.4

3.5

mg/l

42.7

27.8

—

231

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.35

3.19

2.9

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

259

1.75

3.15

3.3

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.97

3.13

1.1

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

2.26

3.13

2.8

2.2

—

(4062490)

146

2.00

3.05

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

517

0.52

3.04

1.8

1.5

mg/l

3.6

3.8

0.04

375

(3028192) IgG subclass 2 [Mass/volume] in Serum

147

1.99

3.00

1.4

g/l

2.9

3.0

0.16

109

(3027135) IgG subclass 1 [Mass/volume] in Serum

147

1.99

3.00

1.4

g/l

7.3

7.0

0.12

108

(3024139) IgG subclass 3 [Mass/volume] in Serum

147

1.99

3.00

1.4

g/l

0.3

0.4

0.85

108

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1182

0.68

2.97

1.6

1.8

—

(40757373) Influenza virus identified in Isolate

3.16

2.93

1.9

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.84

2.92

2.9

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.84

2.92

2.9

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

4.72

2.92

1.4

1.1

—

(3037756) Immunofixation for Serum or Plasma

366

1.60

2.91

1.3

1.5

—

(3024471) HLA-A [Type]

3.35

2.90

1.0

—

(3024932) HLA-DR beta [Type]

3.35

2.90

1.1

1.2

—

(3011288) Drugs identified in Urine by Screen method

236

1.75

2.90

4.2

2.3

—

(3025315) Body weight

5.40

2.87

5.1

3.5

—

(4198724)

2.94

2.86

3.3

1.8

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

165

1.89

2.81

2.3

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

158

1.91

2.81

1.2

1.4

—

29.8

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.41

2.80

4.1

3.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

131

2.00

2.76

1.1

1.0

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

152

1.92

2.75

1.1

1.3

—

(4268621)

145

1.94

2.75

2.5

2.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

276

2286

1.24

2.74

1.6

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

380

1.57

2.74

1.4

1.8

mg/l

12.2

11.7

0.16

347

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.22

2.68

1.3

1.8

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

2.22

2.64

1.2

1.4

ug/l

2.1

3.8

1.77

(3016879) Cocaine [Presence] in Urine

313

1.61

2.62

3.4

1.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

141

1.93

2.60

1.4

1.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.00

2.60

0.0

1.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.61

2.57

1.6

1.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.61

2.57

1.6

1.2

96.2

89.2

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

7.16

2.55

4.6

3.1

umol/l

25.0

24.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

164

1.84

2.54

2.4

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

165

1.83

2.49

2.4

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

777

0.65

2.47

1.4

1.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

272

1.63

2.45

1.3

1.2

—

414.3

—

(3019225) pH of Specimen

119

1553

0.75

2.40

6.3

3.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.34

2.39

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

153

1.84

2.38

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

214

1.70

2.33

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.19

2.31

4.8

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.22

2.30

1.8

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

170

1.78

2.29

1.1

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

127

1.90

2.26

2.5

2.6

nmol/l

19.8

17.4

0.39

118

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

121

1.91

2.21

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

121

1.91

2.21

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

121

1.91

2.21

1.2

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.42

2.20

1.2

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

569

1.40

2.18

3.1

1.8

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.63

2.18

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

2.11

2.12

1.2

1.1

—

(3044941) Cell count panel - Synovial fluid

291

1.56

2.12

1.6

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

123

1.88

2.11

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

123

1.88

2.11

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

123

1.88

2.11

1.2

1.1

—

(4010399)

148

1178

1.28

2.11

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

168

1.74

2.08

2.5

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

168

1.74

2.08

2.5

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

168

1.74

2.08

2.5

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

5.01

2.07

1.8

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

5.01

2.07

4.6

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

334

1.51

2.05

3.4

1.8

—

(3027008) Opiates [Presence] in Urine

336

1.50

2.00

3.4

1.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

529

1.39

1.98

3.0

1.7

—

(3028300) Cannabinoids [Presence] in Urine

337

1.50

1.97

3.5

1.8

—

(3044290) Cell count panel - Cerebral spinal fluid

329

1.50

1.97

2.8

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

105

1.91

1.95

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

187

1.67

1.94

1.1

1.3

—

(3012516) Albumin [Mass/volume] in Urine

536

4847

1.15

1.94

3.6

3.2

mg/l

576.4

290.8

0.66

386

3093

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.76

1.93

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.76

1.93

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

3.19

1.88

3.0

3.4

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

3.19

1.88

6.0

6.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

189

1.65

1.88

3.9

3.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

435

3887

1.15

1.86

6.4

3.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

2.09

1.86

1.1

1.2

ratio

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

744

1.32

1.85

1.0

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

371

3287

1.16

1.78

1.9

1.7

pmol/l

468.5

35078578.9

3.29

306

2751

(3023410) Appearance of Cerebral spinal fluid

185

1.63

1.75

2.3

2.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

507

1.37

1.75

2.1

1.8

—

(3022621) pH of Urine by Test strip

124

991

1.27

1.75

3.4

2.8

—

(3042631) Mycobacterium sp identified in Specimen

217

1.58

1.74

2.7

2.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.51

1.74

1.0

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

323

1.47

1.72

1.9

iu/l

3.2

5.9

1.60

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.92

1.72

1.0

1.3

—

(3017732) Neutrophils [#/volume] in Blood

1035

0.75

1.70

4.5

3.1

e9/l

5.2

4.1

1.70

788

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

179

1.63

1.70

1.2

1.1

—

(3027944) Amphetamines [Presence] in Urine

333

1.45

1.68

2.7

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.19

1.67

1.5

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

104

1.84

1.67

1.7

2.0

ug/min

50.2

85.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

105

1.82

1.63

2.5

3.0

40.3

37.7

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.33

1.60

1.5

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

2.51

1.59

2.9

1.6

—

(3019977) pH of Arterial blood

1.89

1.55

6.1

3.4

7.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

107

1.78

1.54

1.1

1.4

mmol/l

9.5

12.1

0.88

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.34

1.52

1.0

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

250

1.49

1.50

1.8

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

154

1.63

1.50

3.5

2.9

70.9

56.6

1.71

100

(3039443) Prostate specific Ag panel - Serum or Plasma

344

0.61

1.50

1.6

1.7

—

(3034426) Prothrombin time (PT)

2.23

1.46

1.1

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

208

1791

1.18

1.45

1.5

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

447

1.35

1.44

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

148

1.63

1.44

4.2

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.13

1.44

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

174

1.56

1.37

1.1

1.3

nmol/l

—

(3028433) Virus identified in Specimen by Culture

2.20

1.37

1.2

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1198

0.80

1.36

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.95

1.36

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

616

0.72

1.35

1.4

1.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

342

1.38

1.32

1.2

1.3

miu/ml

221.7

222.0

—

146

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

113

1.69

1.32

1.7

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

552

5113

1.11

1.31

4.3

3.8

mg/mmol

14.7

8.5

2.25

383

3223

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

2.78

1.28

1.6

1.1

u/l

26.6

1825.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.89

1.28

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.72

1.27

1.5

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

154

1.57

1.26

1.2

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.40

1.24

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.40

1.24

1.8

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

619

1.27

1.23

1.4

1.8

u/l

36.9

39.2

0.43

534

(40768795) Lymph node Pathology biopsy report

139

1.59

1.23

1.5

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

147

1.57

1.23

2.0

1.3

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

144

0.48

1.20

2.9

13.6

13.3

—

144

(3011985) Renin [Units/volume] in Plasma

205

1.47

1.20

1.7

1.4

mu/l

51.1

97.1

0.45

181

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

2.31

1.18

9.0

6.0

umol/l

41.5

41.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.11

1.18

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.78

1.17

1.0

—

(3045142) Bone marrow Pathology biopsy report

215

1.45

1.16

1.5

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

360

1.34

1.15

1.9

1.7

e6/l

34.4

34.8

0.01

270

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

360

1.34

1.15

1.9

1.8

e6/l

858.5

906.8

0.03

282

(3038515) Glucose [Moles/volume] in Venous blood

320

0.65

1.15

5.7

3.0

mmol/l

6.5

7.5

1.93

314

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

112

0.45

1.13

1.8

1.7

—

(3035933) Granulocytes/100 leukocytes in Blood

1.97

1.11

1.2

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

260

1.39

1.10

1.7

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1553

15198

1.11

1.06

4.5

4.6

mmol/l

6.0

0.57

1390

13753

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

1.71

1.05

1.5

1.6

u/field

2.9

2.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.64

1.03

1.5

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

412

1.29

1.02

1.9

1.6

e6/l

13815.9

12765.3

0.09

289

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

188

1.44

1.01

1.7

1.4

pmol/l

314.6

343.0

0.12

150

(3045424) Erythrocytes [Presence] in Urine

222

1.40

1.00

2.2

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

317

1.33

1.00

1.5

—

(4024509)

133

0.52

0.98

1.1

1.5

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

1.81

0.98

1.8

1.4

—

59.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

389

0.72

0.98

5.7

4.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

0.97

0.0

1.2

—

27.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

222

0.63

0.95

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.77

0.94

1.0

1.2

—

11.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.62

0.93

1.3

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.23

0.93

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.23

0.93

1.5

1.1

mmol/l

2.1

1.8

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

147

1284

1.16

0.93

2.4

2.1

nmol/l

10.6

12.9

3.02

132

1125

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

401

1.28

0.92

2.0

1.8

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

261

1.35

0.91

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

460

0.76

0.88

2.3

1.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.79

0.87

1.0

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.86

0.87

1.8

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.86

0.87

1.8

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.86

0.87

1.8

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

290

1.32

0.86

1.2

u/ml

49.2

50.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

217

2396

0.89

0.84

1.3

1.2

u/ml

10.7

12.7

0.19

886

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

111

0.54

0.83

1.2

1.6

—

(4146454)

178

0.62

0.83

3.6

2.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

122

1062

1.16

0.83

1.8

1.9

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1478

14486

1.08

0.82

5.8

mmol/mol

40.0

0.05

1375

13321

(3041354) Potassium [Moles/volume] in Venous blood

189

0.63

0.81

4.9

2.2

mmol/l

4.3

4.0

0.59

189

(3035285) Chloride [Moles/volume] in Venous blood

189

0.63

0.81

4.9

2.2

mmol/l

107.4

105.4

0.60

189

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.73

0.79

1.6

1.1

iu/ml

192.9

246.0

—

(3016018) Differential panel - Cerebral spinal fluid

173

1.39

0.79

3.7

1.9

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.67

0.78

1.3

1.7

pmol/l

13.4

14.5

—

(3017569) Oxygen content in Arterial blood

1.63

0.78

2.1

3.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

671

6406

1.07

0.77

4.7

5.1

ug/l

3.2

3.1

0.06

562

5736

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

279

0.71

0.75

1.5

—

(3045462) Protein/Creatinine [Ratio] in Urine

2.09

0.74

6.0

10.0

g/mol

39.1

95.0

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.67

0.74

1.8

1.1

121.2

107.6

—

(3029075) Extractable nuclear Ab panel - Serum

1.67

0.74

1.0

—

(3013512) EKG study

422

4484

0.92

0.74

4.3

3.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

231

0.69

0.73

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

1.85

0.73

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.64

0.73

1.7

2.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

183

0.65

0.72

4.9

2.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.67

0.68

9.3

1.7

—

(1002224) Polysomnography panel

549

1.19

0.67

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.63

0.67

2.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

383

0.78

0.65

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1497

15208

0.93

0.65

4.1

4.4

mmol/l

1.4

1.5

5.42

1342

13886

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.57

0.65

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.57

0.65

2.5

2.4

—

(3047189) Immunofixation for 24 hour Urine

1.52

0.62

1.9

1.6

—

(3022689) Creatine [Moles/volume] in Urine

1.67

0.61

3.4

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.60

0.61

2.0

2.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

113

1.42

0.61

1.6

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

103

911

1.14

0.61

1.2

iu/ml

207.0

158.3

0.36

314

(3001729) Color of Synovial fluid

0.00

0.60

0.0

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.53

0.59

1.3

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.48

0.57

2.0

1.1

g/l

0.3

—

(4034850)

549

0.83

0.57

17.3

10.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

449

1.19

0.55

1.4

1.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.58

0.54

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.54

0.53

1.0

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

146

0.68

0.52

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.45

0.51

1.0

1.1

u/ml

0.2

0.5

—

(3020491) Glucose [Moles/volume] in Blood

110

1.37

0.48

2.1

mmol/l

8.9

6.9

0.77

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

110

0.64

0.48

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.49

0.47

1.6

1.2

ug/l

7.7

8.8

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.49

0.47

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

1.47

0.47

2.0

3.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

182

1.27

0.46

1.2

—

39.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

235

2501

0.93

0.46

1.3

iu/ml

37.3

40.1

0.09

760

(3044242) Glucose [Moles/volume] in Arterial blood

1.40

0.44

6.1

2.8

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.61

0.43

2.2

1.8

—

(3003740) Influenza virus B Ag [Presence] in Specimen

221

1.22

0.42

1.0

1.1

—

(44813793)

0.64

0.42

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

794

1.11

0.42

4.0

3.2

—

(3044927) Protein electrophoresis panel - Urine

167

1.26

0.41

1.0

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

250

0.80

0.41

1.1

u/ml

11.0

5.4

—

146

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

222

1.22

0.41

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.40

0.0

11.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.40

0.0

1.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

14.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

183

0.76

0.40

1.7

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

186

1.24

0.40

1.6

2.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.47

0.40

1.0

1.9

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.40

0.0

1.1

—

0.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

106

1.32

0.39

1.0

1.3

u/ml

1.0

3.6

—

(3015183) Erythrocyte sedimentation rate

1.34

0.38

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

397

0.85

0.37

1.1

—

(4211845)

1.39

0.37

2.0

3.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

375

1.15

0.36

1.3

1.2

u/ml

3.7

7.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

245

0.81

0.36

1.1

u/ml

1.0

1.5

—

129

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

157

0.76

0.35

1.5

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

157

0.76

0.35

1.5

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

208

1.20

0.35

1.0

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

156

0.77

0.34

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

156

0.77

0.34

1.5

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1517

15316

0.96

0.34

4.2

4.4

mmol/l

4.4

4.6

14.81

1373

14086

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

340

0.85

0.34

1.6

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

340

1.15

0.33

1.3

1.6

nmol/l

0.8

0.05

287

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

393

3791

1.05

0.33

2.9

3.1

ug/l

0.8

0.22

270

2597

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

0.70

0.33

1.0

3.0

u/l

201.0

198.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

435

4207

1.04

0.33

1.8

1.6

mmol/l

1.6

1.4

3.74

369

3548

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.69

0.33

1.2

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

285

0.84

0.32

1.0

1.2

u/ml

0.7

2.9

2.28

136

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.28

0.32

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.31

0.31

3.3

3.8

—

(3017704) Immunofixation for Urine

1.31

0.31

1.4

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.35

0.31

1.0

1.1

miu/ml

2631.6

1574.7

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

131

0.76

0.30

3.9

4.1

u/ml

35.6

49.2

—

131

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.25

0.29

11.1

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.25

0.29

11.3

2.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

237

0.84

0.27

1.1

u/ml

1.7

3.8

—

(3004616) Nuclear Ab [Presence] in Serum

172

0.81

0.27

1.1

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1.23

0.27

3.3

2.4

umol/l

58.9

53.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

113

1.24

0.26

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

376

1.12

0.26

3.3

2.2

ug/min

79.3

99.8

0.29

230

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1577

15655

1.04

0.26

4.7

5.0

mmol/l

2.5

2.7

16.34

1421

14296

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

273

1.14

0.25

1.2

1.1

iu/ml

2.7

119.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

359

1.12

0.24

1.7

1.6

mmol/l

3.8

3.7

0.10

335

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

126

0.79

0.24

1.1

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.74

0.24

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.71

0.24

1.3

1.0

—

(21494434) Karyotype in Bone marrow

172

1.16

0.22

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

167

0.84

0.21

1.4

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.19

0.21

2.2

2.7

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3024316) Viscosity of Plasma

0.00

0.21

0.0

1.2

—

1.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

109

1033

1.06

0.21

1.2

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

126

1.19

0.21

1.3

2.2

u/field

2.7

2.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

0.21

0.0

1.5

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

0.00

0.20

0.0

1.0

—

172.6

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.20

0.0

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.25

0.20

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.25

0.20

1.0

1.1

—

(3008898) HLA-B27 [Presence]

452

1.09

0.19

1.0

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

100

949

1.06

0.19

1.9

1.8

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.15

0.19

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.13

0.18

1.3

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.13

0.18

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

128

1.17

0.18

7.1

4.9

u/ml

10.5

40.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

185

0.86

0.18

1.1

u/ml

2.1

5.7

—

(3032773) Endomysium IgG Ab [Titer] in Serum

152

0.85

0.17

1.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

226

1.11

0.15

1.2

1.1

—

(40768800) Prostate Pathology biopsy report

430

1.07

0.14

1.1

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

325

0.92

0.13

1.7

1.8

pmol/l

176.1

208.5

1.27

306

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

159

0.88

0.13

1.1

u/ml

1.0

0.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

530

5230

1.02

0.12

3.8

4.4

21.4

21.6

0.12

206

2633

(40768793) Breast Pathology biopsy report

293

0.92

0.12

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

354

0.93

0.12

1.5

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.11

0.09

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

159

1560

1.02

0.07

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1465

14694

0.99

0.07

4.1

3.9

mmol/l

1.4

1.3

5.92

1309

13313

(42870560) Thyrotropin [Units/volume] in Cord blood

0.83

0.07

1.0

mu/l

5.9

8.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.07

0.07

10.6

6.6

—

(4027681)

1.03

0.07

1.3

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.12

0.07

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

173

0.92

0.06

1.0

1.1

u/ml

1.5

5.1

—

(3024263) Appearance of Synovial fluid

102

0.88

0.06

1.3

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

104

0.86

0.06

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

446

0.96

0.06

1.6

1.8

nmol/l

37.3

41.1

1.08

433

(1617658) Protocol used for examination of sentinel lymph nodes

110

1.09

0.05

1.2

1.0

—

(4094501)

454

0.97

0.04

1.2

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

201

0.94

0.04

1.1

u/ml

2.1

2.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

109

0.92

0.04

1.2

1.1

mg/l

243.8

278.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

109

0.92

0.04

1.6

1.3

u/ml

0.6

2.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

128

0.94

0.02

1.5

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

132

1.06

0.02

1.4

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

831

0.99

0.02

1.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

103

1.07

0.02

1.0

1.3

u/ml

1.3

3.4

—

(3005033) Fetal Nuchal fold Thickness US

127

0.94

0.01

1.5

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

207

2081

0.99

0.01

20.3

7.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

114

1.05

0.00

1.2

1.1

—

115.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

185

0.97

0.00

1.6

3.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

242

0.99

0.00

2.0

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

132

0.98

0.00

1.2

1.4

u/l

36.3

24.0

0.42

109

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.1

—

7.7

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.4

—

0.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.9

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3006598) pH of Arterial cord blood

0.98

0.00

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.3

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.2

—

1.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.0

—

2.3

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.00

0.00

1.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3014271) Vancomycin [Susceptibility]

0.95

0.00

3.7

2.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.0

2.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.4

—

153.9

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_ARTIF_OPENI_STATUS – Artificial opening status

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Artificial opening status

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Artificial opening status (Z21_ARTIF_OPENI_STATUS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints